Barely Significant
← all excerpts

Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design.

PLoS One · 2012 · PMC3254606 · PMID 22253690

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantp<0.01actually significant
We quantified the relative phophorylation level of Bcr-Abl p210 by immunoblotting with phospho-Bcr-Abl-specific antibodies and thus we could assess the inhibition of activated Bcr-Abl by apoptin, which was highly significant (p<0.01, 0.04) in both cell lines.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.